Cargando…
Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19
High levels of autoimmune antibodies are observed in COVID-19 patients but their specific contribution to disease severity and clinical manifestations remains poorly understood. We performed a retrospective study of 115 COVID-19 hospitalized patients with different degrees of severity to analyze the...
Autores principales: | Gomes, Claudia, Zuniga, Marisol, Crotty, Kelly A, Qian, Kun, Tovar, Nubia Catalina, Lin, Lawrence Hsu, Argyropoulos, Kimon V, Clancy, Robert, Izmirly, Peter, Buyon, Jill, Lee, David C, Yasnot-Acosta, Maria Fernanda, Li, Huilin, Cotzia, Paolo, Rodriguez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441539/ https://www.ncbi.nlm.nih.gov/pubmed/34504035 http://dx.doi.org/10.26508/lsa.202101180 |
Ejemplares similares
-
To Be or Not to Be Treated: That Is the Question in Managing a Fetus With Cardiac Injury Exposed to Anti‐SSA/Ro
por: Buyon, Jill, et al.
Publicado: (2022) -
Linking anti-Ro antibodies to fibrosis in congenital heart block: translation to a clinical trial
por: Buyon, Jill P, et al.
Publicado: (2014) -
Autoimmune Congenital Complete Heart Block: How Late Can It Occur?
por: Makadia, Luv, et al.
Publicado: (2023) -
Atypical memory B-cells and autoantibodies correlate with anemia during Plasmodium vivax complicated infections
por: Rivera-Correa, Juan, et al.
Publicado: (2020) -
Gut dysbiosis and the clinical spectrum in anti-Ro positive mothers of children with neonatal lupus
por: Clancy, Robert M., et al.
Publicado: (2022)